An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice
Clinical trial NCT05494606 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05494606
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-08-15
- Primary completion
- 2028-03-01
- Enrollment
- 785
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.